For over 20 years, Dr. Anand and his team of scientists and clinicians have been involved in the development and utilization of stem cell-based clinical protocols for stem cell therapy, and clinicians have been treating the patients regularly using adult stem cells since 2000.
Headquartered in San Diego, California, USA., GIOSTAR has been the world’s leading stem cell research company and till today keeps developing treatments for human degenerative diseases, muscular injuries and anti-aging treatments with unique and state-of-the-art stem cell-based therapies.
Adult stem cell therapy and technology is a well-developed medical field internationally and within the United States. Although it is approved and regulated by many authorities throughout the world that are the local equivalent of the FDA, the FDA oversees the practice in the United States.
The FDA has approved several stem cell products that you may find here on the fda website https://www.fda.gov/biologicsbloodvaccines/cellulargenetherapyproducts/approvedproducts/default.htm.
Autologous Stem Cell Therapy falls under this guidance document issued by the FDA on November 17th, 2017, https://www.federalregister.gov/documents/2017/11/17/2017-24839/same-surgical-procedure-exception-questions-and-answers-regarding-the-scope-of-the-exception.
GIOSTAR’s main purpose is: To give people all over the world a new way of living.
INSTITUTE OF REGENERATIVE MEDICINE AND STEM CELL TREATMENT HOSPITALS
GIOSTAR is using adult stem cell for its autologous and allogeneic stem cells transplant to treat patients, following the highest medical standards. The adult stem cell technology is well developed and being used regularly in clinical practice. Our clinicians are licensed to treat the patients using autologous (their own) and allogeneic (from others) adult stem cells for certain diseases. We are the leading private organization, which has state of art excellence in extraction of stem cell from a human body and use it for therapy. Our clinicians are treating the patients regularly using adult stem cells since 2000.
GIOSTAR is a coalition of esteemed and illustrious scientific minds in the field of stem cell science, genetics and cancer research. For over 15 years GIOSTAR team of scientists and clinicians have been involved in the development and utilization of stem cell based clinical protocols related to stem cell transplants.
The GIOSTAR team includes international leaders in the field of adult stem cell, embryonic stem (ES) cells and Induced Pluripotent Stem (IPS) cells research and technologies. The GIOSTAR team is the first in demonstrating the significance of ES cell use for the development of therapies for several degenerative diseases related to tissue and organs. The publications of these therapies have been thoroughly investigated and documented by many noted journals of medicine. GIOSTAR is leading the most advanced research in the field of ES cells and IPS cells to develop new therapies for future clinical use.
GIOSTAR advanced Stem Cell science will be used to treat qualified patients on needed basis.